Medicine and Dentistry
Adenocarcinoma
8%
Amino Acid
9%
Biodistribution
11%
Biological Marker
11%
Breast Cancer
12%
Cancer
9%
Carbon 11
10%
Chemoradiotherapy
9%
Clinical Trial
7%
Computer Assisted Tomography
10%
Diagnosis
10%
Diseases
12%
Fluorine-18
51%
Fluorodeoxyglucose
23%
Fluorodeoxyglucose F 18
41%
Gallium 68
23%
Ganglioglioma
13%
Glioblastoma
11%
Hypoxia
7%
Imaging Agent
6%
Intracranial Tumor
8%
Lutetium 177
12%
Lymph Node
11%
Magnetic Resonance Imaging
15%
Malignant Neoplasm
16%
Metabolism
8%
Metastatic Carcinoma
8%
Methionine
8%
Molecular Imaging
21%
Neoadjuvant Therapy
7%
Neoplasm
92%
Neuroendocrine Tumor
7%
Non Small Cell Lung Cancer
11%
Nuclear Medicine
9%
Oncology
8%
Overall Survival
11%
Polyethylene Terephthalate
79%
Positron Emission Tomography
100%
Positron Emission Tomography-Computed Tomography
60%
Prostate Cancer
33%
Prostate Specific Antigen
6%
Prostate Specific Membrane Antigen
20%
Radiation Therapy
19%
Radiation Treatment Planning
6%
Radioactive Tracer
23%
Single-Photon Emission Computed Tomography
8%
Standardized Uptake Value
12%
Tetraxetan
10%
Treatment Response
8%
Zirconium 89
8%
Keyphrases
18F-FDG PET-CT
11%
18F-fluorodeoxyglucose (18F-FDG)
17%
18F-fluorodeoxyglucose PET
8%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
14%
After Injection
9%
Biodistribution
15%
Brain Tumor
8%
Breast Cancer
8%
Chemotherapy
10%
Computed Tomography
9%
FDG PET-CT
10%
FDG Uptake
14%
Fluorodeoxyglucose
11%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
33%
Gallium-68
14%
Glioblastoma
7%
Glioma
9%
Hypoxia
9%
In Vivo Imaging
7%
Lutetium-177 (177Lu)
17%
Lymph Node
10%
Magnetic Resonance Imaging
10%
Metabolic Activity
7%
Metabolic Imaging
7%
Molecular Imaging
17%
Non-responders
10%
Non-small Cell Lung Cancer (NSCLC)
10%
Nuclear Medicine
8%
Overall Survival
10%
PARP Inhibitor (PARPi)
13%
PET Imaging
20%
PET Scan
8%
Positron Emission Tomography
69%
Positron Emission Tomography-computed Tomography (PET-CT)
48%
Prostate Cancer
18%
Prostate-specific Antigen
26%
Radiation Treatment Planning
9%
Radiotherapy
9%
Radiotracer
8%
Response Assessment
8%
Response Prediction
7%
Single-photon Emission Computed Tomography (SPECT)
10%
Standardized Uptake Value
17%
SUVmax
9%
Treatment Monitoring
9%
Tumor
60%
Tumor Metabolism
9%
Tumor Response
12%
Tumor Tissue
7%
Zirconium-89 (89Zr)
11%